Membrane Bioreactor Market Size, Share & Trends Analysis Report By Product (Hollow Fiber, Flat Sheet, Multi-tubular), By Configuration (Submerged, Side Stream), By Application (Municipal, Industrial), By Region, And Segment Forecasts, 2025 - 2030

Membrane Bioreactor Market Size, Share & Trends Analysis Report By Product (Hollow Fiber, Flat Sheet, Multi-tubular), By Configuration (Submerged, Side Stream), By Application (Municipal, Industrial), By Region, And Segment Forecasts, 2025 - 2030


Enzyme Replacement Therapy Market Growth & Trends

The global enzyme replacement therapy market size is estimated to reach USD 17.26 billion by 2030, registering to grow at a CAGR of 9.0% from 2025 to 2030 according to a new report by Grand View Research, Inc. As per the Genetic and Rare Diseases Information Center or GARD, a rare disease is defined as a condition that affects lesser than 200,000 individuals. These disorders are also called orphan diseases due to the lack of support exhibited by pharmaceutical companies previously. Since the passing of the Orphan Drug Act of 1983 in the U.S., several large pharmaceutical and biopharmaceutical companies have invested heavily in the development of orphan drugs. Thus, rising awareness, increasing R&D investment, growth in the number of lysosomal storage and genetic disorders, and easy drug approval process are factors propelling the market growth during the forecast period.

According to data from the National Institutes of Health, it is estimated that over 25 million Americans suffer from rare diseases. These facts are indicative of the fact that although the number of these ailments is low, individuals suffering from these are large. Some of the most common lysosomal storage disorders that make use of enzyme replacement therapy are Gaucher, Fabry, Pompe, MPS, SCID, and Shwachman-Diamond Syndrome among others.

In the recent past, these disorders have been gaining significant attention, impacting growth positively. Various grants and acts are in place to accommodate drug makers to invest in the development of orphan drugs. Orphan Drug Designation Program, Rare Pediatric Disease Priority Review Voucher Program, Humanitarian Use Device (HUD) Program, and Orphan Products Clinical Trials Grants Program are programs that aid in the development of orphan drugs.

The rising use of enzyme replacement therapy in home care and infusion centers are gaining traction in the market. Specialized infusion centers such as these are anticipated to witness the highest CAGR during the forecast period. Hospitals held the largest segmental share owing to easy accessibility and ability to treat a wide range of ailments.

Enzyme Replacement Therapy Market Report Highlights
  • Gaucher disease held the dominant position in the market and accounted for the largest revenue share of 32.6% in 2024, driven by the increasing prevalence and awareness of the condition, leading to more patients being diagnosed and treated.
  • Imiglucerase dominated the market and accounted for the largest revenue share of 20.2% in 2024, owing to the rising prevalence of Gaucher disease, which necessitates effective treatment options. In addition, as awareness and diagnosis rates improve, more patients are being identified, increasing demand for imiglucerase.
  • The parenteral route of administration dominated the market and accounted for the largest revenue share of 80.9% in 2024. This growth is attributed to its ability to facilitate rapid absorption and effective drug delivery. In addition, this method allows for intravenous infusions, which are essential for delivering large molecules such as enzymes directly into the bloodstream, ensuring immediate therapeutic effects
  • Infusion centers led the market and accounted for the largest revenue share of 40.8% in 2024, driven by their specialized focus on intravenous treatments. These centers provide a controlled environment for administering ERT, ensuring patient safety and comfort during infusions.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope and Assumptions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Membrane Bioreactor Market Variables, Trends, & Scope
3.1. Market Segmentation & Scope
3.2. Concentration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Regulatory Framework
3.5. Technology Overview
3.6. Membrane Bioreactor Market - Market dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.6.3. Market Opportunity Analysis
3.6.4. Market Challenge Analysis
3.7. Industry Analysis Tools: Membrane Bioreactor Market
3.7.1. Porter’s Analysis
3.7.2. Macroeconomic Analysis
3.8. Economic Mega Trends Analysis
Chapter 4. Membrane Bioreactor Market: Product Estimates & Trend Analysis
4.1. Product Movement Analysis & Market Share, 2024 & 2030
4.2. Hollow Fiber
4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Flat Sheet
4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4. Multi-Tubular
4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Membrane Bioreactor Market: Configuration Estimates & Trend Analysis
5.1. Configuration Movement Analysis & Market Share, 2024 & 2030
5.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.2. Submerged
5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. Side Stream
5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Membrane Bioreactor Market: Application Estimates & Trend Analysis
6.1. Application Movement Analysis & Market Share, 2024 & 2030
6.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.2. Municipal
6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Industrial
6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Membrane Bioreactor Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2024 & 2030
7.2. North America
7.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.2.2. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.2.3. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.2.4. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.2.5. U.S.
7.2.5.1. U.S. Macroeconomic Outlook
7.2.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.2.5.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.2.5.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.2.5.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.2.6. Canada
7.2.6.1. Canada Macroeconomic Outlook
7.2.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.2.6.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.2.6.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.2.6.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.2.7. Mexico
7.2.7.1. Mexico Macroeconomic Outlook
7.2.7.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.2.7.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.2.7.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.2.7.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.3.3. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.3.4. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.3.5. UK
7.3.5.1. UK Macroeconomic Outlook
7.3.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.5.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.3.5.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.3.5.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.3.6. Germany
7.3.6.1. Germany Macroeconomic Outlook
7.3.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.6.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.3.6.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.3.6.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.3.7. France
7.3.7.1. France Macroeconomic Outlook
7.3.7.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.7.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.3.7.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.3.7.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.3.8. Italy
7.3.8.1. Italy Macroeconomic Outlook
7.3.8.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.8.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.3.8.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.3.8.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.4.3. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.4.4. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.4.5. China
7.4.5.1. China Macroeconomic Outlook
7.4.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.5.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.4.5.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.4.5.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.4.6. India
7.4.6.1. India Macroeconomic Outlook
7.4.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.6.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.4.6.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.4.6.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.4.7. Japan
7.4.7.1. Japan Macroeconomic Outlook
7.4.7.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.7.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.4.7.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.4.7.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. South Korea Macroeconomic Outlook
7.4.8.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.8.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.4.8.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.4.8.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.5.3. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.5.4. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.5.5. Brazil
7.5.5.1. Brazil Macroeconomic Outlook
7.5.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.5.5.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.5.5.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.5.6. Argentina
7.5.6.1. Argentina Macroeconomic Outlook
7.5.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.5.6.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.5.6.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.6.3. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.6.4. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Macroeconomic Outlook
7.6.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.6.5.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.6.5.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
7.6.6. Saudi Arabia
7.6.6.1. Saudi Arabia Macroeconomic Outlook
7.6.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6.3. Market estimates and forecasts by product, 2018 - 2030 (USD Million)
7.6.6.4. Market estimates and forecasts by application, 2018 - 2030 (USD Million)
7.6.6.5. Market estimates and forecasts by configuration, 2018 - 2030 (USD Million)
Chapter 8. Membrane Bioreactor Market: Competitive Analysis
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Overview
8.5. Product Benchmarking
8.6. Company Market Positioning
8.7. Company Market Share Analysis, 2024
8.8. Company Heat Map Analysis, 2024
8.9. Strategy Mapping
8.10. Company Profiles
8.10.1. General Electric
8.10.1.1. Participant’s overview
8.10.1.2. Financial performance
8.10.1.3. Product benchmarking
8.10.1.4. Recent developments
8.10.2. B&P Water Technologies S.r.l.
8.10.2.1. Participant’s overview
8.10.2.2. Financial performance
8.10.2.3. Product benchmarking
8.10.2.4. Recent developments
8.10.3. CITIC Envirotech Ltd.
8.10.3.1. Participant’s overview
8.10.3.2. Financial performance
8.10.3.3. Product benchmarking
8.10.3.4. Recent developments
8.10.4. MANN+HUMMEL
8.10.4.1. Participant’s overview
8.10.4.2. Financial performance
8.10.4.3. Product benchmarking
8.10.4.4. Recent developments
8.10.5. Suez
8.10.5.1. Participant’s overview
8.10.5.2. Financial performance
8.10.5.3. Product benchmarking
8.10.5.4. Recent developments
8.10.6. Calgon Carbon Corporation
8.10.6.1. Participant’s overview
8.10.6.2. Financial performance
8.10.6.3. Product benchmarking
8.10.6.4. Recent developments
8.10.7. Veolia
8.10.7.1. Participant’s overview
8.10.7.2. Financial performance
8.10.7.3. Product benchmarking
8.10.7.4. Recent developments
8.10.8. Reynolds Culligan
8.10.8.1. Participant’s overview
8.10.8.2. Financial performance
8.10.8.3. Product benchmarking
8.10.8.4. Recent developments
8.10.9. Kemira
8.10.9.1. Participant’s overview
8.10.9.2. Financial performance
8.10.9.3. Product benchmarking
8.10.9.4. Recent developments
8.10.10. Buckman
8.10.10.1. Participant’s overview
8.10.10.2. Financial performance
8.10.10.3. Product benchmarking
8.10.10.4. Recent developments
8.10.11. Mitsubishi Chemical Corporation
8.10.11.1. Participant’s overview
8.10.11.2. Financial performance
8.10.11.3. Product benchmarking
8.10.11.4. Recent developments
8.10.12. Aquatech International LLC
8.10.12.1. Participant’s overview
8.10.12.2. Financial performance
8.10.12.3. Product benchmarking
8.10.12.4. Recent developments
8.10.13. Danaher Corporation
8.10.13.1. Participant’s overview
8.10.13.2. Financial performance
8.10.13.3. Product benchmarking
8.10.13.4. Recent developments
8.10.14. Toray Industries
8.10.14.1. Participant’s overview
8.10.14.2. Financial performance
8.10.14.3. Product benchmarking
8.10.14.4. Recent developments
8.10.15. Kubota Corporation
8.10.15.1. Participant’s overview
8.10.15.2. Financial performance
8.10.15.3. Product benchmarking
8.10.15.4. Recent developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings